Inventiva SA header image

Inventiva SA

IVA

Equity

ISIN FR0013233012 / Valor 35598121

Euronext - Euronext Paris (2026-08-18)

EUR 3.92-3.21%

Inventiva SA
UMushroom community rating:

0.00 0 votes No rating yet

NegativeNeutralPositive

About company

Inventiva SA is a clinical-stage biopharmaceutical company based in France, publicly traded on Euronext, that discovers and develops oral small-molecule therapies aimed primarily at liver, fibrotic and metabolic diseases and certain rare genetic disorders. Its most advanced program is lanifibranor (IVA337), a pan-PPAR agonist being developed as a treatment for non-alcoholic steatohepatitis (NASH), and the company also pursues drug candidates for lysosomal storage and muscle-related conditions. Inventiva advances compounds through preclinical and clinical studies and seeks collaborations and licensing arrangements to support development and potential commercialization.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

7.26%1Y

17.6%3Y

-59.9%5Y

Performance

65.0%1Y

61.7%3Y

62.6%5Y

Volatility

944 M

Market cap (USD)

342,274

Daily traded volume (Shares)

/

1 day high/low (USD)

0.00 / 0.00

52 weeks high/low (USD)

01 January, 2022

Dividend ex-date

0.00

Dividend (USD)

0.00%

Dividend yield (p.a.)

0.002022

0.002023

0.002024

Est dividend (USD)

0.00%2022

0.00%2023

0.00%2024

Est dividend yield

10.00

P/E ratio

00.002022

00.002023

00.002024

Est P/E ratio

0.00

EPS (USD)

0.002022

0.002023

0.002024

Est EPS (USD)

Ratings & reviews

0.00

0 votes

Performance:

0.00

Innovation:

0.00

Society:

0.00

Nature:

0.00

EQUITIES OF THE SAME SECTOR

Globus Medical Inc

Globus Medical Inc Valor: 18329123

Annual Return

-50%0%+50%

Risk level

110

1.55%USD 86.44

CHAPTERS Group AG

CHAPTERS Group AG Valor: 2175722

Annual Return

-50%0%+50%

Risk level

110

-4.25%EUR 45.10

Sotera Health Company

Sotera Health Company Valor: 57897071

Annual Return

-50%0%+50%

Risk level

110

-1.54%USD 18.51

Denali Therapeutics Inc

Denali Therapeutics Inc Valor: 39149539

Annual Return

-50%0%+50%

Risk level

110

-0.16%USD 24.31

OKYO Pharma Limited

OKYO Pharma Limited Valor: 127195533

Annual Return

-50%0%+50%

Risk level

110

-0.66%USD 1.51

Herbalife Ltd

Herbalife Ltd Valor: 2002103

Annual Return

-50%0%+50%

Risk level

110

2.92%USD 12.34

Molina Healthcare Inc

Molina Healthcare Inc Valor: 1538184

Annual Return

-50%0%+50%

Risk level

110

0.27%USD 203.61

Quest Diagnostics Inc

Quest Diagnostics Inc Valor: 566162

Annual Return

-50%0%+50%

Risk level

110

0.31%USD 236.25

Haemonetics Corp

Haemonetics Corp Valor: 937449

Annual Return

-50%0%+50%

Risk level

110

15.93%USD 104.65

Boston Scientific Corp

Boston Scientific Corp Valor: 913577

Annual Return

-50%0%+50%

Risk level

110

-1.87%USD 50.47

SIX

FactSet

Clearbit

Logos provided by Clearbit